{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:43:26Z","timestamp":1791225806651,"version":"4.1.0"},"reference-count":19,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2015,11,3]],"date-time":"2015-11-03T00:00:00Z","timestamp":1446508800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0141687","type":"journal-article","created":{"date-parts":[[2015,11,3]],"date-time":"2015-11-03T14:05:31Z","timestamp":1446559531000},"page":"e0141687","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":38,"title":["A Phase I, Open-Label Trial, Evaluating the Safety and Immunogenicity of Candidate Tuberculosis Vaccines AERAS-402 and MVA85A, Administered by Prime-Boost Regime in BCG-Vaccinated Healthy Adults"],"prefix":"10.1371","volume":"10","clinical-trial-number":[{"clinical-trial-number":"nct01683773","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Sharon","family":"Sheehan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie A.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iman","family":"Satti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Hokey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veerabadran","family":"Dheenadhayalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Stockdale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zita-Rose","family":"Manjaly Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Minhinnick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morven","family":"Wilkie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Vermaak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew K.","family":"O\u2019Shea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Grazia","family":"Pau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Versteege","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Macaya","family":"Douoguih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Hendriks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerald","family":"Sadoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Landry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Moss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"McShane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,11,3]]},"reference":[{"key":"ref1","unstructured":"WHO. Global tuberculosis report 2014. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\/tb\/publications\/global_report\/en\/\" xlink:type=\"simple\">http:\/\/www.who.int\/tb\/publications\/global_report\/en\/<\/ext-link>. Accessed 19 November 2014."},{"issue":"9517","key":"ref2","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0140-6736(06)68507-3","article-title":"Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness","volume":"367","author":"BB Trunz","year":"2006","journal-title":"Lancet"},{"issue":"9","key":"ref3","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jama.1994.03510330076038","article-title":"Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature","volume":"271","author":"GA Colditz","year":"1994","journal-title":"JAMA"},{"issue":"6","key":"ref4","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1093\/ije\/22.6.1154","article-title":"Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis","volume":"22","author":"LC Rodrigues","year":"1993","journal-title":"Int J Epidemiol"},{"key":"ref5","unstructured":"WHO. The Stop TB Strategy. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\/tb\/strategy\/stop_tb_strategy\/en\/\" xlink:type=\"simple\">http:\/\/www.who.int\/tb\/strategy\/stop_tb_strategy\/en\/<\/ext-link>. Accessed 19 November 2014."},{"issue":"11","key":"ref6","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1038\/nm1128","article-title":"Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans","volume":"10","author":"H McShane","year":"2004","journal-title":"Nat Med"},{"issue":"12","key":"ref7","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1016\/j.vaccine.2012.01.048","article-title":"A recombinant adenovirus expressing immunodominant TB antigens can significantly enhance BCG-induced human immunity","volume":"30","author":"DF Hoft","year":"2012","journal-title":"Vaccine"},{"issue":"1\u20132","key":"ref8","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.tube.2003.08.010","article-title":"Immunology of tuberculosis and implications in vaccine development","volume":"84","author":"JL Flynn","year":"2004","journal-title":"Tuberculosis"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1600-065X.2008.00693.x","article-title":"Early T-cell responses in tuberculosis immunity","volume":"225","author":"GM Winslow","year":"2008","journal-title":"Immunol Rev"},{"issue":"7383","key":"ref10","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nature10766","article-title":"Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys","volume":"482","author":"DH Barouch","year":"2012","journal-title":"Nature"},{"issue":"2","key":"ref11","doi-asserted-by":"crossref","first-page":"e31208","DOI":"10.1371\/journal.pone.0031208","article-title":"Phase Ia clinical evaluation of the safety and immunogenicity of the Plasmodium falciparum blood-stage antigen AMA1 in ChAd63 and MVA vaccine vectors","volume":"7","author":"SH Sheehy","year":"2012","journal-title":"PLoS One"},{"issue":"12","key":"ref12","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1164\/rccm.200910-1484OC","article-title":"The novel tuberculosis vaccine, AERAS-402, induces robust and polyfunctional CD4+ and CD8+ T cells in adults","volume":"181","author":"B Abel","year":"2010","journal-title":"American journal of respiratory and critical care medicine"},{"issue":"7","key":"ref13","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.vaccine.2012.12.042","article-title":"Comparing the safety and immunogenicity of a candidate TB vaccine MVA85A administered by intramuscular and intradermal delivery","volume":"31","author":"J Meyer","year":"2013","journal-title":"Vaccine"},{"issue":"7","key":"ref14","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/cyto.a.22478","article-title":"OMIP-022: Comprehensive assessment of antigen-specific human T-cell functionality and memory","volume":"85","author":"AJ Graves","year":"2014","journal-title":"Cytometry Part A: the journal of the International Society for Analytical Cytology"},{"issue":"11","key":"ref15","doi-asserted-by":"crossref","first-page":"5046","DOI":"10.1128\/JCM.41.11.5046-5052.2003","article-title":"Quantifying adenovirus-neutralizing antibodies by luciferase transgene detection: addressing preexisting immunity to vaccine and gene therapy vectors","volume":"41","author":"MC Sprangers","year":"2003","journal-title":"J Clin Microbiol"},{"issue":"1","key":"ref16","doi-asserted-by":"crossref","first-page":"50","DOI":"10.4161\/hv.22464","article-title":"Safety and immunogenicity of an FP9-vectored candidate tuberculosis vaccine (FP85A), alone and with candidate vaccine MVA85A in BCG-vaccinated healthy adults: a phase I clinical trial","volume":"9","author":"R Rowland","year":"2013","journal-title":"Human vaccines & immunotherapeutics"},{"issue":"10","key":"ref17","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S1473-3099(14)70845-X","article-title":"Safety and immunogenicity of a candidate tuberculosis vaccine MVA85A delivered by aerosol in BCG-vaccinated healthy adults: a phase 1, double-blind, randomised controlled trial","volume":"14","author":"I Satti","year":"2014","journal-title":"The Lancet Infectious diseases"},{"issue":"5","key":"ref18","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.molimm.2009.11.005","article-title":"Humoral immunity in tuberculin skin test anergy and its role in high-risk persons exposed to active tuberculosis","volume":"47","author":"L Encinales","year":"2010","journal-title":"Molecular immunology"},{"issue":"8","key":"ref19","first-page":"542","article-title":"Role of complement activation and antibody in the interaction between Mycobacterium tuberculosis and human macrophages","volume":"50","author":"S Manivannan","year":"2012","journal-title":"Indian J Exp Biol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0141687","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T06:43:41Z","timestamp":1540017821000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0141687"}},"subtitle":[],"editor":[{"given":"David Joseph","family":"Diemert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,11,3]]},"references-count":19,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2015,11,3]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0141687","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,3]]}}}